$Avenue Therapeutics (ATXI.US)$ Maxim Group analyst [Share L...
$Avenue Therapeutics (ATXI.US)$ Maxim Group analyst Jason McCarthy maintained a Buy rating on Avenue Therapeutics (ATXI – Research Report) yesterday and set a price target of $0.75.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment